These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24649559)

  • 1. [Contraindications and limitations of medically assisted procreation].
    Leperlier F; Bancquart J; Fréour T; Barrière P
    Rev Prat; 2014 Jan; 64(1):99-102. PubMed ID: 24649559
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome.
    Gurgan T; Demirol A; Guven S; Benkhalifa M; Girgin B; Li TC
    Fertil Steril; 2011 Jul; 96(1):53-7. PubMed ID: 21621772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An eye to the future.
    Rosenwaks Z; Benadiva C
    Semin Reprod Med; 2010 Nov; 28(6):540. PubMed ID: 21082513
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood group and ovarian hyperstimulation syndrome.
    Bellver J; Ferrando M; Garrido N; Pellicer A
    Fertil Steril; 2010 Jan; 93(1):270-1. PubMed ID: 19683228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian hyperstimulation syndrome: a preventable syndrome?
    Rosenwaks Z; Benadiva C
    Semin Reprod Med; 2010 Nov; 28(6):437-9. PubMed ID: 21082500
    [No Abstract]   [Full Text] [Related]  

  • 6. Assisted conception. III--problems with assisted conception.
    Braude P; Rowell P
    BMJ; 2003 Oct; 327(7420):920-3. PubMed ID: 14563758
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles.
    Oyawoye OA; Chander B; Hunter J; Gadir AA
    MedGenMed; 2005 Aug; 7(3):60. PubMed ID: 16369286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovarian hyperstimulation syndrome: report of six cases].
    Basly M; Ben Mleh H; Ben Jemaâ S; Masri A; Chibani M; Ben Ali I; Massoudi L; Radhouane R
    Tunis Med; 2008 Jan; 86(1):94-6. PubMed ID: 19472717
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical considerations arising from the use of assisted reproductive technologies.
    Klipstein S
    Semin Reprod Med; 2012 Apr; 30(2):146-51. PubMed ID: 22549714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
    Owj M; Tehrani-Nejad ES; Amirchaghmaghi E; Baghestani AR; Ahmadi J
    Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low tolerance for complications.
    Donoso P; Devroey P
    Fertil Steril; 2013 Aug; 100(2):299-301. PubMed ID: 23806852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian hyperstimulation syndrome and complications of ART.
    Vloeberghs V; Peeraer K; Pexsters A; D'Hooghe T
    Best Pract Res Clin Obstet Gynaecol; 2009 Oct; 23(5):691-709. PubMed ID: 19632900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and management of ovarian hyperstimulation syndrome.
    Vlahos NF; Gregoriou O
    Ann N Y Acad Sci; 2006 Dec; 1092():247-64. PubMed ID: 17308149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future developments to minimize ART risks.
    Marzal A; Holzer H; Tulandi T
    Semin Reprod Med; 2012 Apr; 30(2):152-60. PubMed ID: 22549715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medically assisted conceptions. Ovarian complications].
    Izard V
    Soins Gynecol Obstet Pueric Pediatr; 1991 Nov; (126):25-7. PubMed ID: 1962268
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intensive therapy of ovarian hyperstimulation syndrome (clinical guidelines)].
    Kulikov AV; Shifman EM; Portnov IG
    Anesteziol Reanimatol; 2015; 60(1):73-6. PubMed ID: 26027232
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of assisted reproductive technology in the United States, 2000-2011.
    Kawwass JF; Kissin DM; Kulkarni AD; Creanga AA; Session DR; Callaghan WM; Jamieson DJ;
    JAMA; 2015 Jan; 313(1):88-90. PubMed ID: 25562272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ovarian hyperstimulation syndrome].
    Fukuda J; Shimizu Y; Tanaka T
    Nihon Rinsho; 2006 Jun; Suppl 2():434-7. PubMed ID: 16817436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extended deep vein thrombosis of the lower limb complicating medically assisted procreation : about an observation].
    Abdellah A; Jamal F
    Pan Afr Med J; 2015; 22():125. PubMed ID: 26889306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of ovarian hyperstimulation syndrome.
    Genazzani AR; Monteleone P; Papini F; Artini PG
    Expert Opin Pharmacother; 2010 Oct; 11(15):2527-34. PubMed ID: 20854183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.